Toll Free: 1-888-928-9744

Myelodysplastic Syndrome Global Clinical Trials Review, H1, 2016

Published: Mar 31, 2016 | Pages: 1436 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Myelodysplastic Syndrome Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, 
 Table of Contents
1 Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Five Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Myelodysplastic Syndrome to Oncology Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Myelodysplastic Syndrome to Oncology Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Myelodysplastic Syndrome Therapeutics Clinical Trials 28 Prominent Drugs 30 Latest Clinical Trials News on Myelodysplastic Syndrome 31 Mar 24, 2016: Preclinical Efficacy Data of Apogenix' APG101 in Myelodysplastic Syndromes Published in Oncotarget 31 Mar 21, 2016: Onconova Enrolls First Patient in Europe for Phase 3 INSPIRE Trial of Rigosertib in Higher-Risk Myelodysplastic Syndromes 31 Mar 16, 2016: Syros Pharmaceuticals to Present Preclinical Data on SY-1425 in Blood Cancers at Upcoming AACR Annual Meeting 32 Mar 16, 2016: Syros Pharmaceuticals to Present Preclinical Data on CDK7 Inhibitor Program in Blood Cancers at Upcoming AACR Annual Meeting 32 Mar 09, 2016: Onconova Announces Publication of Rigosertib Phase 3 ONTIME Data in Lancet Oncology 33 Feb 15, 2016: Phase 3 Study Demonstrates Aranesp (Darbepoetin Alfa) Reduces Red Blood Cell Transfusions In Patients With Myelodysplastic Syndrome 33 Feb 03, 2016: Trillium Therapeutics Doses First Patient With TTI-621, a Novel Immune Checkpoint Inhibitor Targeting CD47 34 Jan 12, 2016: FORMA Therapeutics Enrolls First Patient in Phase 1 Study of FT-1101 in Advanced Hematological Malignancies 34 Jan 11, 2016: Celator Pharmaceuticals Announces Participation in Cardiff University Clinical Trial in Adults with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome (AML19) 35 Jan 11, 2016: Bellicum Pharmaceuticals Announces Submission of BPX-701 Clinical Trial Protocols for Review by the NIH RAC 36 Clinical Trial Profile Snapshots 37 Appendix 1433 Abbreviations 1433 Definitions 1433 Research Methodology 1434 Secondary Research 1434 About GlobalData 1435 Contact Us 1435 Disclaimer 1435 Source 1436
List of Tables
Myelodysplastic Syndrome Therapeutics, Global, Clinical Trials by Region, 2016* 6 Myelodysplastic Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Myelodysplastic Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Myelodysplastic Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Myelodysplastic Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Myelodysplastic Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Myelodysplastic Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13 Myelodysplastic Syndrome Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14 Proportion of Myelodysplastic Syndrome to Oncology Clinical Trials, G7 Countries (%), 2016* 15 Myelodysplastic Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Myelodysplastic Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Myelodysplastic Syndrome to Oncology Clinical Trials, E7 Countries (%), 2016* 18 Myelodysplastic Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Myelodysplastic Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Myelodysplastic Syndrome Therapeutics, Global, Clinical Trials by Phase, 2016* 21 Myelodysplastic Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22 Myelodysplastic Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Myelodysplastic Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Myelodysplastic Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Myelodysplastic Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26 Myelodysplastic Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Myelodysplastic Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29 Myelodysplastic Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30


List of Figures
Myelodysplastic Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Myelodysplastic Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Myelodysplastic Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Myelodysplastic Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Myelodysplastic Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Myelodysplastic Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Myelodysplastic Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13 Myelodysplastic Syndrome Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14 Proportion of Myelodysplastic Syndrome to Oncology Clinical Trials, G7 Countries (%), 2016* 15 Myelodysplastic Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Myelodysplastic Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Myelodysplastic Syndrome to Oncology Clinical Trials, E7 Countries (%), 2016* 18 Myelodysplastic Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Myelodysplastic Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Myelodysplastic Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21 Myelodysplastic Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22 Myelodysplastic Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Myelodysplastic Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Myelodysplastic Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Myelodysplastic Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26 Myelodysplastic Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Myelodysplastic Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Myelodysplastic Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 GlobalData Methodology 1434

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global automotive coatings market size is likely to be valued at USD 27.7 billion by 2022; as per a new research report by Radiant Insights, Inc. Vehicle aesthetics, UV radiation and temperature variation protection and enhance durability are certain

Read More...

Europe industrial air filtration market size is projected to reach USD 1,690.8 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing implementation in various industries such as metal, cement and food & beverages among ot

Read More...

Global PP (Polypropylene) nonwoven fabric market size is anticipated to be valued at USD 30.6 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing usage of hygiene products such as incontinence products and baby diapers is

Read More...

Global compressed air treatment equipment market is projected to reach USD 8.59 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing implementation of this equipment in various industry sectors such as healthcare & pharmace

Read More...

Global electric water heaters market is expected to be valued at USD 29,322.4 million by 2022, as per a new research report by Radiant Insights, Inc. Escalating demand across extensive range of domestic applications is expected to drive demand. Evolv

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify